You have 9 free searches left this month | for more free features.

Condition

HNSCC (1)

Lymphoma, Malignant (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

M.D. Anderson Cancer Center (1)

PIQUR Therapeutics AG (1)

Intervention

bimiralisib (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

bimiralisib

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

HNSCC Trial in Houston (Bimiralisib)

Terminated

HNSCC

Bimiralisib

Houston, Texas

M.D. Anderson Cancer Center

Dec 22, 2021

Lymphoma, Malignant Trial in Worldwide (bimiralisib)

Completed

Lymphoma, Malignant

bimiralisib

New York, New York
+11 more

Aug 27, 2019